Finance

Beta
Lists
NRC:NASDAQ
NRC Health
$21.64
+3.99%
(+0.83) 1D
$21.64
0.00% (0.00)
After hours
Closed: Jun 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NRC...
Open
$20.83
High
$21.69
Low
$20.22
Mkt. cap
487.69M
Avg. vol.
152.32K
Volume
19.00
Dividend
2.96%
Quarterly dividend
$0.16
Ex-dividend date
Jun 26, 2026
P/E ratio
54.52
52-wk high
$22.79
52-wk low
$11.01
EPS
$0.40
Beta
0.37
Shares outstanding
22.54M
No. of employees
357
Open
$20.83
High
$21.69
Low
$20.22
Mkt. cap
487.69M
Avg. vol.
152.32K
Volume
19.00
Dividend
2.96%
Quarterly dividend
$0.16
Ex-dividend date
Jun 26, 2026
P/E ratio
54.52
52-wk high
$22.79
52-wk low
$11.01
EPS
$0.40
Beta
0.37
Shares outstanding
22.54M
No. of employees
357
News stories
From sources across the web
Profile
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. Wikipedia
About NRC Health
CEOMichael Hays
Employees357
Founded1981
HeadquartersLincoln, Nebraska, United States
SectorHealth care provider
Analyst ratings
Based on 1 analyst giving stock ratings to NRC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for NRC in the last 3 months
Highest
Current $21.64
$23.00 (+6.28%)
Average
$23.00 (+6.28%)
Lowest
$23.00 (+6.28%)
Analyst
Recommendation
Action
Price target
Projected
Date
Constantine Davides
Citizens JMP
Buy
Initiated
$23.00
+6.3%
06/22/2026
Last report
Apr 28, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.21 / -
0.00%miss
Revenue / Est. (USD)
34.80M / -
0.00%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
34.04M
34.61M
35.19M
34.80M
Cost of goods sold
12.97M
12.40M
13.94M
13.65M
Cost of revenue
12.97M
12.40M
13.94M
13.65M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.73M
12.27M
7.79M
13.42M
Operating expense
19.48M
14.47M
9.94M
15.59M
Total operating expenses
32.45M
26.87M
23.87M
29.23M
Operating income
1.59M
7.74M
11.32M
5.57M
Other non operating income
4.00K
-45.00K
-61.00K
30.00K
EBT including unusual items
581.00K
6.27M
3.27M
4.38M
EBT excluding unusual items
581.00K
6.27M
9.92M
4.38M
Income tax expense
687.00K
2.15M
1.47M
1.16M
Effective tax rate
118.24%
34.29%
45.00%
26.42%
Other operating expenses
-
-
-
-
Net income
-106.00K
4.12M
1.80M
3.22M
Net profit margin
-0.31%
11.91%
5.11%
9.26%
Earnings per share
-
-
-
-
Interest and investment income
21.00K
41.00K
29.00K
35.00K
Interest expense
-1.03M
-1.46M
-1.37M
-1.26M
Net interest expenses
-1.01M
-1.42M
-1.34M
-1.22M
Depreciation and amortization charges
1.74M
2.20M
2.14M
2.17M
EBITDA
3.33M
9.93M
13.47M
7.74M
Gain or loss from assets sale
-
-
61.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more